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ABSTRACT
Objective To analyze oocyte competence in gonadotropin-
releasing hormone agonist (GnRHa) stimulation cycles
with regard to maturity, fertilization and blastocyst rate,
as well as clinical outcome (pregnancy and live-birth
rate), in relation to follicular volume, measured by
three-dimensional transvaginal sonography (3D-TVS),
and follicular fluid composition.
Methods This was a prospective single-center study con-
ducted between June 2012 and June 2014, including 118
ovum pick-ups with subsequent embryo transfer. Ovarian
stimulation was performed using the GnRHa long pro-
tocol. Of 1493 follicles aspirated individually, follicular
volume was evaluated successfully in 1236 using auto-
mated 3D-TVS during oocyte retrieval. Oocyte maturity
and blastocyst development were tracked according to
follicular volume. Intrafollicular concentrations of estra-
diol, testosterone, progesterone, luteinizing hormone,
follicle-stimulating hormone and granulocyte–colony
stimulating factor were quantified by immunoassay. Clin-
ical outcome, in terms of implantation rate, (clinical)
pregnancy rate, miscarriage and live-birth rate (LBR),
was evaluated.
Results Follicles were categorized, according to their
volume, into three arbitrary groups, which included 196
small (8–12 mm/0.3–0.9 mL), 772 medium (13–23 mm/
1–6 mL) and 268 large (≥ 24 mm/> 6 mL) follicles.
Although oocyte recovery rate was significantly lower
in small follicles compared with medium and large ones
(63.8% vs 76.6% and 81.3%, respectively; P < 0.001),
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similar fertilization rates (85.1% vs 75.3% and 81.4%,
respectively) and blastocyst rates (40.5% vs 40.6% and
37.2%, respectively) per mature metaphase II oocyte were
observed. A trend towards higher LBR after transfer
of blastocysts derived from small (< 1 mL) follicles
compared with medium (1–6 mL) or large (> 6 mL)
follicles (54.5% vs 42.0%, and 41.7%, respectively)
was observed. No predictive value of follicular fluid
biomarkers was identified.
Conclusions Our data indicate that the optimal fol-
licular volume for a high yield of good quality blas-
tocysts with good potential to lead to a live birth
is 13–23 mm/1–6 mL. However, oocytes derived from
small follicles (8–12 mm/0.3–0.9 mL) still have the capac-
ity for normal development and subsequent delivery of
healthy children, suggesting that aspiration of these folli-
cles should be encouraged as this would increase the total
number of blastocysts retrieved per stimulation. Copy-
right © 2017 ISUOG. Published by John Wiley & Sons
Ltd.
INTRODUCTION
During controlled ovarian stimulation (OS), follicles of
different size develop, which are monitored by transvagi-
nal sonography (TVS). The decision of the follicle size
at which final oocyte maturation should be triggered is
a critical step in OS. It is well known that oocyte matu-
rity is linked with follicle size1. One of the most widely
applied protocols is administering the trigger when sev-
eral follicles have reached a diameter of ≥ 18 mm1–6.
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However, this strategy was based on the previous finding
that small follicles are associated with low oocyte recovery
rates2,7,8. Furthermore, reduced maturity and fertilization
capacity for oocytes retrieved from small follicles were
reported, followed by the recommendation not to aspi-
rate this pool of follicles2,7–10. However, other studies did
not find differences in oocyte recovery rate11 or fertiliza-
tion rate (FR), between small and large follicles5,12. Most
importantly, some publications demonstrated decreased
FR and developmental competence in oocytes derived
from very large (> 23 mm) follicles, indicating adverse
effects of prolonged stimulation9,13. Similarly, controver-
sial results on the relationship between follicular size and
embryo cleavage rates were reported5,6,10,11. These dis-
cordant findings might be attributed to differences in OS
protocols, patient characteristics, workflows, techniques
to measure follicular volume and size, methods of oocyte
insemination (in-vitro fertilization (IVF) or intracytoplas-
mic sperm injection (ICSI)) and analysis of endpoints
(fertilization and cleavage rates, and embryo quality). To
date, few studies have analyzed the relationship between
blastocyst development or clinical outcome and follicular
size following one-by-one follicle measurement10,11,14.
To shed more light on the controversial findings regard-
ing the optimal follicular size for oocyte retrieval evalu-
lated by conventional two-dimensional TVS, we aimed
to perform a prospective study using three-dimensional
(3D) TVS, which is considered a more accurate method
for evaluation of spherical and non-spherical follicle vol-
umes. We investigated the correlation between follicle size
and oocyte competence as well as embryo development
to blastocyst stage. In addition, clinical outcome was
evaluated in terms of implantation, pregnancy, clinical
pregnancy and live-birth (LBR) rates. In order to sub-
stantiate our findings, follicular fluid (FF) samples from
different follicle cohorts were collected to identify putative
biomarkers for oocyte quality and competence in relation
to follicle growth.
METHODS
Patients and study design
This cross-sectional, prospective, single-center study was
conducted from June 2012 to June 2014 in our clinic
in Pilsen, Czech Republic. The study was approved by
the Ethics Committee of the University Hospital and
Medical Faculty, Charles University, Pilsen. Patients were
recruited during their first consultation at the clinic.
Informed consent for evaluation of the anonymized
outcome data was given by all patients. Inclusion criteria
were ≤ 43 years and undergoing OS performed using the
gonadotropin-releasing hormone agonist (GnRHa) long
protocol. Exclusion criteria were diagnosis of polycystic
ovary syndrome, hormone-related female infertility,
persistent inflammation of the reproductive tract including
severe endometriosis, endometritis, structural uterine
anomaly, history of recurrent (three or more) implantation
failure in previous IVF cycles, or recurrent (three or
more) miscarriage. Only one cycle of each patient
was included. Patient data, including maternal age,
height, body mass index (BMI), weight, reasons for
infertility, preconditions and previous IVF attempts
and pregnancies, were collected routinely. Data from
118 IVF cycles and 1493 aspirated follicles with
individual 3D ultrasound follicle measurements and
single embryo cultures were included. Data on hormonal
stimulation and medication of the patient as well as
the embryo culture were recorded. Blastocyst transfer
and the IVF outcome were documented and recorded
using the in-house software DynaMed (IMA-Systems
Information-Technology, Bregenz, Austria). Outcome
parameters analyzed were the number of cumulus oocyte
complexes (COCs) retrieved, number of metaphase-II
(MII) oocytes, fertilization and blastocyst rates, as well
as clinical parameters including (clinical) pregnancy,
implantation and LBR. Additionally, the concentrations
of hormones and cytokines in the follicular fluid were
determined.
Controlled ovarian stimulation
OS was performed using the GnRHa long protocol, as
previously described15. After confirmed downregulation
(using Decapeptyl; Ferring Arzneimittel, Vienna, Aus-
tria), stimulation was performed with human menopausal
gonadotropin (hMG) (Merional; IBSA, Lugano, Switzer-
land). Transvaginal scans were performed every 2–3 days,
starting on days 6–7 after start of stimulation. When the
majority of recruited follicles reached a spherical diameter
of 16–23 mm (volume 2–6 mL), final oocyte maturation
was triggered by injection of 10 000 IU of human chori-
onic gonadotropin (hCG) (Pregnyl; Organon, Vienna,
Austria), 36 h before oocyte retrieval.
Oocyte retrieval and one-by-one follicle volume
estimation
During aspiration, patients were under intravenous
sedoanalgesia (1% Propofol MCT Fresenius (Fresenius
Kabi, Germany) and fentanyl (Fentanyl; hameln phar-
maceuticals ltd, Gloucester, UK)) performed by an
anesthetist. All oocyte retrievals and scans were per-
formed by two trained physicians using standardized
protocols. No modifications were made with regard
to the operative technique used during the study.
A detailed schematic presentation of the workflow is
shown in Figure S1. During ovum pick-up (OPU), an
initial overview of the whole ovary was performed by
3D ultrasound with automated volume calculation using
SonoAVC software (GE Medical Systems Kretztechnik
GmbH & Co, Zipf, Austria), as described previously16.
All applications of SonoAVC were performed using a
Voluson E8 according to the manufacturer (GE Medical
Systems Kretztechnik GmbH & Co) and to the indications
of Ata and Tulandi16 and Murtinger et al.17. Hence, the
aspiration needle (G17 IVF; TIK, Kobarid, Slovenia) was
rinsed and filled with flushing medium (Modified Ham’s
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F-10; Irvine Scientific, Santa Ana, CA, USA) and follicles
were aspirated one-by-one, with aspiration pressure set
at 105 mmHg, under ultrasound guidance and automated
single volume calculation to assure puncture of the spe-
cific follicle, with confirmation by manual measurement
of the volume of the native aspirated FF in scaled aspira-
tion tubes. Follicles for which the volume calculated by
SonoAVC differed by more than 20% from the volume
measured manually were excluded from the study.
When the COC was found immediately in aspirated
native FF, the needle was moved to the next follicle. If the
COC was not retreived in native FF, follicles were flushed
between one and five times until it was obtained. If the
COC was still not retrieved in the flushing medium, the
aspiration needle was removed from the ovary and rinsed
with flushing medium to eventually rescue a COC stuck
in the needle lumen.
We ensured that, for each patient, all follicles (and
follicles of all size groups) were punctured. The aspiration
of antral follicles, reflected by a follicular size of
2–6 mm18, was avoided because of the technical limit
of the aspiration needles used. The total duration of the
procedure for each patient was approximately 20–35 min.
No complication occurred during OPU.
The oocyte recovery rate was determined by the
number of COCs retrieved in relation to the number
of follicles aspirated. Aspirated follicles were grouped,
according to follicular volume, into the following
arbitrary groups: small follicles with a volume of
0.3–0.9 mL, corresponding to a spherical diameter of
8–12 mm; medium size follicles with a volume of 1–6 mL,
corresponding to a spherical diameter of 13–23 mm; and
large follicles with a volume of >6 mL, corresponding
to a spherical diameter of ≥ 24 mm. It was ensured that
in each participating patient, follicles of all three groups
were aspirated.
Embryo culture and blastocyst transfer
Three to four hours after oocyte retrieval, COCs
were denuded and oocyte maturity was assessed19.
The number of MII oocytes was calculated per follicle
aspirated or per COC obtained. Oocytes were fertilized
using intracytoplasmic morphologically selected injection
(IMSI) by default20. Embryo culture was performed in
single embryo culture (one embryo per culture well;
Nunc A/S, Roskilde, Denmark). Fertilization was assessed
16–18 h after IMSI by observation of the presence of
two pronuclei (2PN). FR was calculated per either
aspirated follicle or COC retrieved, or MII oocyte
obtained. Cleavage rate was evaluated on day 3. Blastocyst
development was assessed on day 5, before the one
or two blastocysts graded morphologically as best were
selected for embryo transfer (ET). Blastocysts were graded
according to the Gardner blastocyst grading scale21.
Blastocysts with expansion 2–6 and Grade A for both
inner cell mass and trophectoderm, or a combination
of Grades A and B, were scored as top blastocysts.
Blastocyst rate was determined per either follicle aspirated
or COCs retrieved, or MII oocyte obtained. Blastocyst
transfer was performed, as previously described, using a
Wallace embryo replacement catheter (Smiths Medical
International, Kent, UK)22. Surplus blastocysts were
vitrified aseptically (Vitrisafe®, IVF-Distribution, GmbH,
Bregenz, Austria) according to Vanderzwalmen et al.23.
Clinical outcome
Only ETs with one or two blastocysts originating from
the same follicle groups were evaluated for the clinical
outcome. Fourteen days after ET, urinary β-hCG was
tested and pregnancy rate was calculated as the number
of patients with positive test in relation to the number
of ETs performed. Clinical pregnancy was detected by
fetal heart beat on ultrasound at 8–12 weeks post-ET.
Clinical pregnancy rate was calculated as the number
of patients with diagnosed clinical pregnancy in relation
to the number of ETs performed24. Implantation rate
was calculated by number of fetal heart beats observed
per number of blastocysts transferred. Miscarriage was
defined as pregnancy loss after detection of fetal heart beat
and before the 21st gestational week. LBR was defined
as a dichotomous variable: one (or more) child born was
considered to be a positive result, and the ratios were
calculated per ET24.
Quantification of intrafollicular biomarkers
Immediately after oocyte retrieval, follicular aspirate
samples were centrifuged at 1500 g. Supernatants were
harvested and stored at –20 ◦C until measurement.
Therefore, only original follicular fluid was used before
flushing to avoid dilution with flushing medium. Only
clear fluids were assayed to avoid distortion by blood
contamination; thus, cloudy and bloodstained samples
were excluded from analysis. Measurements were per-
formed in duplicate. Intrafollicular concentrations of
estradiol (E2), testosterone (T), progesterone (P), luteiniz-
ing hormone (LH), follicle-stimulating hormone (FSH)
and granulocyte–colony stimulating factor (G–CSF) were
quantified as potential biomarkers for oocyte quality and
developmental competence25,26. E2 and P were quan-
tified by chemiluminescent microparticle immunoassays
(CMIA) on the ARCHITECT i2000 system (Abbott,
Dublin, Ireland) following the manufacturer’s protocol
using a four-parameter calibration curve. T was quanti-
fied by ELISA (Testosterone ELISA kit; Alpha Diagnostic
International, San Antonio, TX, USA) on a Synergy HT
(Biotek, Winooski, VT, USA) reader, according to the
manufacturer’s protocol, using a five-parameter calibra-
tion curve. FSH, LH and G–CSF were quantified by MAP
(Milliplex MAP Kit; Millipore, Billerica, MA, USA) on
a Luminex® 200™ (Luminex Corporation, Austin, TX,
USA), according to the manufacturer’s protocol, using a
five-parameter calibration curve.
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Statistical analysis
Sample size was calculated based on both of the main
outcome parameters, namely oocyte recovery rate and
blastocyst rate, applying a 15% minimum clinically
relevant difference, a Type-I error of α = 0.05 and
1–β = 0.8, resulting in a minimum of 169 cases per
group. Statistical difference in oocyte retrieval, oocyte
maturation, FR and blastocyst rate, as well as in the
clinical parameters implantation rate, (clinical) pregnancy
rate and LBR, were calculated using Pearson’s chi-square
and Fisher’s exact tests. A 95% CI of the relative risk
and risk difference was applied. An error of α < 0.05
was considered statistically significant. Furthermore, a
post-hoc power analysis on clinical outcome (birth rate)
was performed, resulting in a 9% power of the test and a
minimum detectable difference for statistical significance
of 29.3% for small vs medium follicles, of 28.0% for
large vs medium follicles and of 40.6% for small vs
large follicles. Differences in means of numerical data
were tested by one-way ANOVA using the F distribution.
Differences in hormone and cytokine concentrations were
calculated using the Student’s t-test. Statistical analysis
was performed using the Statistical Package for Social
Sciences (SPSS) software version 22.0 for Windows (IBM
SPSS Statistics, Armonk, NY, USA).
RESULTS
Follicular growth under the GnRHa long protocol
Automated 3D ultrasound investigation of follicular
growth at the time of OPU showed that, out of all
detected follicles, 16.3% had a volume of > 6 mL
(≥ 24 mm spherical diameter), 60.6% had a volume of
1–6 mL (13–23 mm spherical diameter) and 23.1% had
a volume of 0.3–0.9 mL (8–12 mm spherical diameter)
(Figure S2).
Subjects
Follicles were individually aspirated in 118 patients. The
demographic data of these patients are shown in Table 1.
The mean dose of hMG applied was 2854 (range,
1350–5475) IU with mean duration of stimulation of
11.5 days. A mean of 14.7 follicles were aspirated per
patient. The overall oocyte recovery rate was 75.6%. Of
1493 follicles aspirated, 1236 could be analyzed, whereas
257 were excluded because of a discrepancy between
FF volume measured manually and volume estimated by
SonoAVC (Figure 1). No loss to follow-up with regard to
IVF outcome was reported after OPU.
Oocyte quality and blastocyst development
Follicles were grouped, according to their volume,
into three arbitrary groups, which included 196 small
(0.3–0.9 mL), 772 medium (1–6 mL) and 268 large
Table 1 Demographics of 118 patients undergoing ovarian
stimulation using gonadotropin-releasing hormone agonist long
protocol
Characteristic Value
Female age (years) 37.0 ± 4.3 (22–43)
BMI (kg/m2) 22.8 ± 3.6 (17.5–38.8)
Total dose hMG (IU) 2854 ± 818 (1350–5475)
Stimulation (days) 11.5 ± 1.5 (8–16)
Endometrium (mm) 9.6 ± 1.4 (6.0–16.1)
Aspirated follicles (n) 12.7 ± 5.5 (2–37)
COCs retrieved (n) 9.8 ± 5.0 (1–33)
Oocyte retrieval rate (%) 77.7
MII rate (%) 79.1
Type of infertility (%)
Primary 48.3
Secondary 51.7
Etiology of infertility (%)
Female factor 13.6
Male factor 43.2
Female and male factor 29.7
Idiopathic 13.6
Values are given as mean ± SD (range) or %. BMI, body mass
index; COC, cumulus oocyte complex; hMG, human menopausal
gonadotropin; MII, metaphase-II oocyte.
(> 6 mL) follicles, all of which were aspirated and evalu-
ated. The COC recovery rate was statistically significantly
lower (P < 0.001) in small follicles (63.8%) compared
with medium (76.6%) and large (81.3%) follicles.
The proportion of MII oocytes per aspirated follicle
was significantly reduced in small follicles, compared
with medium and large follicles (37.8% vs 64.0% and
70.1%, respectively; P < 0.001; Table 2). The same
trend was observed when the rate of MII oocytes was
calculated per retrieved COC (MII/COC rate, 59.2% in
small follicles vs 83.6% in medium follicles and 86.2%
in large follicles; P < 0.001), showing that even when
an oocyte is retrieved from small follicles, it has a lower
capability of being mature.
The rate of 2PN was significantly lower in small folli-
cles than in medium and large follicles, when calculated
per number of aspirated follicles (32.1% vs 51.7% and
57.1%, respectively; P < 0.001) or per COC retrieved
(50.4% vs 67.5% and 70.2%, respectively; P < 0.001)
(Table 2). However, FR did not differ when calculating
the rate of 2PN per MII between the three follicle groups
(2PN/MII: 85.1% in small vs 75.3% in medium and
81.4% in large follicles). Similarly, a slight, but not
statistically significant, difference was found between the
groups in the rate of abnormal fertilization, as defined by
the observation of either one or three or more pronuclei
per MII oocyte. Specifically, abnormal fertilization was
observed in 3.8% of small, 2.3% of medium and 2.1% of
large follicles. Similarly, no statistically significant differ-
ence was found in embryo cleavage rate per MII oocytes
on day 3. Similar cleavage rates were observed in small
(77.3%), medium (77.7%) and large (80.3%) follicles.
Finally, a lower blastocyst rate was observed in small
compared with medium or large follicles per aspirated
follicle (15.3% vs 27.9% and 26.1%, respectively) or
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2018; 51: 118–125.
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per COC (24.0% vs 36.4% and 32.1%, respectively),
although the difference was statistically significant only
between small and medium follicles (P < 0.05; Table 2).




































Figure 1 Flowchart of follicle aspiration procedure and outcome
measures in 118 patients undergoing ovarian stimulation using
gonadotropin-releasing hormone agonist long protocol. MII,
metaphase II; OPU, ovum pick-up.







(≥ 24 mm/>6 mL) P*
Follicles analyzed (n) 196 772 268
COCs retrieved (n) 125 591 218
COCs/follicle (%) 63.8 76.6 81.3 <0.001†‡, NS§
MII (n) 74 530 188
MII/follicle (%) 37.8 64.0 70.1 <0.001†‡, NS§
MII/COC (%) 59.2 83.6 86.2 <0.001†‡, NS§
2PN (n) 63 399 153
2PN/follicle (%) 32.1 51.7 57.1 <0.001†‡, NS§
2PN/COC (%) 50.4 67.5 70.2 <0.001†‡, NS§
2PN/MII (%) 85.1 75.3 81.4 NS†‡§
Blastocysts (n) 30 215 70
Blastocysts/follicle (%) 15.3 27.9 26.1 < 0.001†, < 0.01‡, NS§
Blastocysts/COC (%) 24.0 36.4 32.1 <0.05†, NS‡§
Blastocysts/MII (%) 40.5 40.6 37.2 NS†‡§
*Statistical significance was evaluated using chi-square test, between: †small and medium follicles; ‡small and large follicles; §medium and
large follicles. 2PN, two pronuclei; COC, cumulus oocyte complex; MII, metaphase II oocyte; NS, not statistically significant.
oocytes were observed in all three groups. This was
also true for blastocyst quality. The rate of top-quality
blastocysts was 12.1% in small, 19.4% in medium and
14.3% in large follicles.
Hormone and cytokine levels in FF
Hormone levels (E2, T, P, LH and FSH) as well as
concentrations of G–CSF were measured in selected
(n = 76) FF samples from the one-by-one 3D ultrasound
volume analysis. We found that the concentration of E2
in FF increased significantly with follicular size, whereas
that of T did not (Table 3). Compared with small follicles,
the E2/T ratio was significantly higher in medium and
large follicles (49.5 vs 85.5 and 138.3, respectively).
A moderate increase in P concentration was observed
in large follicles (P < 0.01) compared with small and
medium ones. No difference in the mean concentrations
of LH, FSH or G–CSF was detected between the different
follicle groups. Interestingly, none of the measured
parameters differed significantly when discriminating
between mature MII oocytes and immature oocytes
(Table S1), or between embryos that reached blastocyst
stage and arrested embryos (Table S2).
Clinical outcome in relation to follicle volume
Only ETs for which an unambiguous allocation of the
outcome to follicle groups was possible (either transfer of
one blastocyst, transfer of two blastocysts derived from
the same follicle group, or transfer of two blastocysts
derived from the different follicle groups resulting in
a dizygotic twin pregnancy) were analyzed for clinical
outcome. The results are shown in Table 4. There was
no statistically significant difference in female age or in
number of transferred blastocysts (single or double ET)
among the three groups. Similar implantation, pregnancy
and clinical pregnancy rates and LBR were observed after
transfer of blastocysts from all three groups of follicles.
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(≥ 24 mm/>6 mL) P*
Follicles (n) 5 39 32
Follicle volume (mL) 0.9 ± 0.1 4.0 ± 1.4 9.0 ± 2.2 <0.001†‡§
E2 (ng/mL) 264 ± 58 347 ± 157 530 ± 324 <0.01‡, < 0.001§
T (ng/mL) 4.1 ± 1.3 4.9 ± 3.5 3.7 ± 1.7 NS†‡§
E2/T ratio 49.5 ± 25.5 85.5 ± 49.8 138.3 ± 56.5 <0.001‡§
P (μg/mL) 9.2 ± 3.0 12.0 ± 4.9 15.4 ± 4.5 <0.05‡, < 0.01§
LH (mU/mL) 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 NS†‡§
FSH (mU/mL) 3.2 ± 1.9 2.9 ± 1.6 3.4 ± 2.3 NS†‡§
G–CSF (pg/mL) 88.8 ± 77.0 52.8 ± 67.4 51.5 ± 23.0 NS†‡§
Values are given as n or mean ± SD. *Statistical significance was evaluated using Student’s t-test, between: †small and medium follicles;
‡small and large follicles; §medium and large follicles. E2, estradiol; FSH, follicle-stimulating hormone; G–CSF, granulocyte–colony
stimulating factor; LH, luteinizing hormone; NS, not significant; P, progesterone; T, testosterone.







(≥ 24 mm/>6 mL)
Embryo transfer (n) 11 50 12
Single 6 29 8
Double 5 21 4
Female age*(years, mean ± SD) 38.3 ± 3.3 37.1 ± 4.8 37.0 ± 2.3
Implantation rate (%) 43.7 33.8 37.5
Pregnancy rate (%) 72.7 46.0 41.7
Clinical pregnancy rate (%) 54.5 44.0 41.7
Miscarriage (n) — 1 —
Live-birth rate (%) 54.5 42.0 41.7
*No statistically significant differences were observed among follicle groups for any parameter.
DISCUSSION
This study demonstrates that oocytes derived from small
follicles have the capacity for normal development and
subsequent delivery of healthy children, indicating the
usefulness of puncturing this follicle cohort.
Previous studies have reported lower oocyte recov-
ery and reduced MII oocyte rates in small follicles
(< 2 mL)2,5,7,27,28. However, according to our data, MII
oocytes from small follicles showed similar capacity
in terms of FR compared with oocytes from follicles
of ≥ 2 mL. This finding is in line with those of some
previous publications5,7,9,10, although not others6,27.
Similarly, published data regarding embryo cleavage
rates and embryo quality in relation to follicle size are
inconsistent9–12.
We also report, for the first time, similar blastocyst rates
in MII oocytes derived from small follicles (0.3–0.9 mL)
compared with larger follicles (1–6 mL and > 6 mL).
A recent study indicated that a larger number of
transferable blastocysts are harvested from follicles of
2–3 mL14; however, this was not confirmed by our data.
According to our data, LBR after ET of small-follicle
blastocysts was similar to that after ET of larger-follicle
blastocysts, suggesting the full capacity of a healthy
live birth in this cohort. Nevertheless, it is worth
mentioning that a trend toward higher LBR after transfer
of blastocysts derived from small and medium, compared
with large, follicles was detected.
Seeing the slight decrease in blastocyst rate and
LBR from follicles of > 6 mL, we assume that a delay
in ovulation trigger might impair the chance of live
birth. This is supported by previous publications; in
consequence, a prolonged stimulation might impair the
IVF outcome9,13,29. However, in our study, follicle size
was not evaluated on the day of trigger-administration
but on the day of pick-up.
In contrast to some previous reports, in our study
no correlation was found between FSH or LH levels
in FF and follicle size, oocyte maturity and embryo
development25,30. A statistically significant difference was
detected in E2 levels and E2/T ratio in FF between small,
medium and large follicles, but no relationship between
E2 levels, E2/T ratio and oocyte maturity or competence
was observed. E2 was reported to enhance oocyte
cytoplasmic maturation, while T levels were associated
with low-quality oocytes and impaired developmental
capacity. A low E2/T ratio was reported to be associated
with follicular atresia and reduced viability25,31. In
our study, P in FF was significantly elevated in large
follicles, but no significant correlation between P and
oocyte maturity and competence was detected. Previously,
higher intrafollicular P concentrations were reported to
be associated with higher implantation rate25,32, while
other studies could not confirm these results26,33,34.
Furthermore, in our study, G–CSF, a cytokine postulated
as a predictor of embryo quality and higher implantation
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rate, was not correlated with follicle size or oocyte
competence26,35,36. However, analysis of biological fluids
such as FF is rather complex as a result of the large
dynamic range of concentrations, the limitations of
technical analysis and possible intrinsic or extrinsic
confounding factors, such as OS37,38. Controversial
findings might also result from the etiology of infertility.
Thus, the robustness of using FF biomarkers for oocyte
competence for clinical application remains to be proven.
The main strength of this study is that it is
the first to analyze oocyte competence, blastocyst
development and clinical outcome in relation to individual
3D ultrasound follicular volume measurements and
simultaneous analysis of intrafollicular hormone and
cytokine concentrations. Limitations of our study include
the small number of patients. Regarding the inevitable
heterogeneity of IVF patients, and thus the confounding
factors, our findings may not be fully representative of the
general IVF population. In particular, but not exclusively,
the heterogeneity with respect to female age might be
a limitation of this work as female age is an important
influencing factor39,40. Bias might also derive from the
defined exclusion criteria that had to be set to provide
valid data, such as exclusion of follicles with deviation in
measured volumes, exclusion of mixed embryo transfers
and inclusion of male factor infertility. Additionally,
considering that only the GnRHa long protocol was used
for OS in this study, the results presented here might not
be applicable to other stimulation protocols. Another
limitation with regard to the analysis of biomarkers
might be the small number of follicles analyzed following
exclusion of numerous samples.
In general, the premature administration of hCG can
result in retention of the oocyte within the follicle or ovula-
tion of oocytes with impaired developmental potential41.
In 1973, Edwards showed a strong relationship between
oocyte recovery and follicle size42. A large number of pub-
lications have since investigated this issue (summarized in
Table S3). In a natural menstrual cycle, pre-ovulatory fol-
licles reach 17–25 mm in diameter43. Data indicate that
in OS, the relationship between size and oocyte maturity
might be different, although a relationship is undoubtedly
present2,6,9.
The estimation of follicular volume in OS is a
difficult task as the shape is often not spherical but
rather ellipsoid or even complex. Calculation of the
follicular volume (Vf = 4/3 × r3 ×π) with conventional
two-dimensional TVS bears the risk of false estimation,
possibly contributing to the controversial publications on
this topic in the past44. In contrast, the 3D ultrasound
technique, as applied in our study, allows a more accurate
volume calculation45,46.
Current clinical practice recommends to schedule
final oocyte maturation according to the size of the
largest follicles and to aspirate only follicles of 1–6 mL
(13–23 mm) in size. Based on the results of our study,
we suggest that this policy should be revised and
that aspiration of small follicles (8–12 mm/0.3–0.9 mL)
should become a routine procedure, seeing that this would
increase the total number of blastocysts retrieved and
therefore could result in higher (cumulative) pregnancy
rate and LBR.
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